Hematology & Oncology in Summit, NJ
6 verified hematology & oncology doctors in Summit.
Hematologist-oncologists treat blood disorders and cancers, coordinating chemotherapy and blood-related care.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the New Jersey State Board of Medical Examiners
Dr. Bonni Guerin, MD
Hematology & Oncology
CMS Open Payments· $222,122 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$222,122
Total received
7
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is higher than 94% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Bonni Guerin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Neil Morganstein, MD
Hematology & Oncology
CMS Open Payments· $626.56 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$626.56
Total received
33
Transactions
22
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 63th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Neil Morganstein do not imply any wrongdoing. Many are meals, education, or research support.
Dr. John Kauh, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sophie Morse, MD
Hematology & Oncology
CMS Open Payments· $16.54 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$16.54
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 39th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Sophie Morse do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Rujuta Saksena, MD
Hematology & Oncology
CMS Open Payments· $51.18 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$51.18
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 44th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Rujuta Saksena do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Paul Markowski, MD
Hematology & Oncology
CMS Open Payments· $51.84 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$51.84
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 44th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Paul Markowski do not imply any wrongdoing. Many are meals, education, or research support.